A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Iowa
University of Wisconsin, Madison
University of Pennsylvania
St. Jude Children's Research Hospital
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts General Hospital
The Netherlands Cancer Institute
City of Hope Medical Center
Institute of Oncology Ljubljana
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Stanford University
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
Thomas Jefferson University
Stanford University
Kepler University Hospital
Memorial Sloan Kettering Cancer Center
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
City of Hope Medical Center
University of Michigan Rogel Cancer Center
The Hospital for Sick Children
Memorial Sloan Kettering Cancer Center
Ottawa Heart Institute Research Corporation
Ruijin Hospital
University of Michigan Rogel Cancer Center
Stanford University
University of Washington
Stanford University
University of Southern California
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Memorial Sloan Kettering Cancer Center
Netherlands Working Group on Immunotherapy of Oncology
Istituto Clinico Humanitas
Center Eugene Marquis
University Health Network, Toronto
Stanford University
University of California, San Francisco
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Odense University Hospital
University of Southern California
Barbara Ann Karmanos Cancer Institute
Washington University School of Medicine